CERTAIN INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE REGISTRANT IF PUBLICLY DISCLOSED. OMISSIONS ARE DESIGNATED AS [***].Alpine Immune Sciences, Inc. • August 11th, 2022 • Pharmaceutical preparations
This letter serves to memorialize the agreement between AbbVie and Alpine to replace Schedule 1.157 of the Agreement with the Schedule 1.157 attached to this letter as Exhibit A.
ALPINE IMMUNE SCIENCES, INC. EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • August 11th, 2022 • Alpine Immune Sciences, Inc. • Pharmaceutical preparations • Washington
THIS EXECUTIVE EMPLOYMENT AGREEMENT (the “Agreement”) is entered into between Alpine Immune Sciences, Inc. (the “Company”), and Andrew Sandler (“Executive”) (collectively referred to as the “Parties” or individually as a “Party”).
